Radioloigand binding techniques were used in combination with in vivo --electrophysiological recording to characterize changes in beta adrenoreceptor activity in various brain areas in rats treated chronically with morphine. Following chronic morphine treatment, the maximum number of specific binding sites for 3H-dihydroalprenolol (3H-DHA) in parietal cortex and hippocampus showed a biphasic change, indicating an initial increase and decrease (relative to controls) in beta adrenoreceptors in these regions with time during withdrawal. No appreciable changes were observed in the dissocation constants for 3H-DHA binding. The changes in cortical beta adrenoreceptor density found in early (8 hr) and later phases (32 hr) of withdrawal were paralled by a selective increase and decrease, respectively, in cortical neuron sensitivity to noradrenerglc stimulation. These result8 suggest a possible linkage between changes in central adrenoreceptor function and the formation and/or expression of opiate dependence.
INTRODUCTION
Considerable evidence indicates that significant components of the opiate withdrawal syndrome may be due to increased central noradrenergic activity. For example, activation of the locus coeruleus (LC) in subhuman primates by means of either electrical or pharmacological stimulation elicits a profile of behavioral and physiological effects strikingly similar to those observed during opiate withdrawal (1). Both morphine and clonidine, an alpha2 adrenerglc agonist, have been shown to block these effects of LC activation (1) and to suppress the acceleration in LC neuron firing and norepinephrine (NE) turnover in brain that occurs during acute opiate withdrawal (1,2). Clonidine has also been shown to alleviate opiate withdrawal symptoms in animals and man (3); an effect which has been attributed to its inhibitory influence on LC-NE neuronal activity. These findings have served to focus attention on central noradrenergic neurons, particularly those of the LC, as a "final common pathway" for the manifestation of the opiate abstinence syndrome. Nevertheless, the finding in recent studies of Increases and decreases in beta and alpha2 adrenergic receptors, respectively, in various brain regions in rata treated chronically with morphine (4, 5, 6) Mlcrolontophoretic testing revealed that the changes In 3H-DBA binding found in parletal cortex during early (8 hr) and later phases (32 hr) of withdrawal were paralleled by a concomitant Increase and decrease, respectively, in postsynaptic sensitivity of cerebrocortlcal neurons to noradrenerglc stlwilatlon (Fig. 1) . In tests on 46 cell-pairs from 13 experiments, the mean threshold currents of NE (27.3 + 1.4nA, S.E.M. ) and IS0 (25.1 + 2.0 nA, S.E.M.) required for depression 03 neurons In chronic morphine-treated rats were significantly less (p<.OOl) than those of control cells (41.5 + 1.9 nA, NE; 41.1 + 2.3 nA, ISO). In subsequent experiments (NE12) on 31 cell-pairs, slgnlflcantly higher (~~001) levels of lontophoretlc NE (45.9 + 2.1 nA, mean + S.E.M.) and IS0 (49.2 + 2.4nA, mean + S.E.M.) were required-to inhibit the-firing of neurons recorded in 32 hr Glthdrawn rats compared to cells in saline-treated controls (23.0 + 1.4 nA, NE; 30.7 2 1.6nA, ISO). No significant differences In chemosensltlvlty to the direct Inhibitory effects of GABA were observed between cells recorded in control, chronic morphine-treated and withdrawn animals. The cells recorded from the morphine-treated (B) and morphine-withdrawn animal (C) show a higher and lower sensitivity, respectively, to the inhibitory actions of both NE and IS0 than does the control cell (A).
DISCUSSION
The results of this study confirm and extend earlier findings (4,s) that chronic, but not acute, administration of morphine results In an Increased 31 number of beta adrenoreceptors in rat cerebral cortex.
Using electrophysiological recording methods in combination with radioligand binding techniques, we were able to demonstrate that the increase in cortical beta adrenoreceptors produced by chronic morphine treatment was paralleled by an enhanced responsiveness of cerebrocortical neurons to NE. Neurons in chronic morphine-treated animals appeared hypersensitive as well to the direct inhibitory action of the beta selective agonist ISO, but not to GABA. It seems likely, therefore, that the increase in cerebrocortical neuron sensitivity to noradrenergic stimulation following long-term morphine administration reflects the emergence of supersensitivity in postsynaptic beta adrenoreceptors, rather than alterations in catecholamine re-uptake or a nonspecific change in cellular excitability. The time course of this observed change in beta receptor activity would support a linkage between the occurrence of beta-adrenergic supersensitivity and the opiate dependent state. Whether such changes in central adrenoreceptor sensitivity contribute in a significant way in the manifestation of the withdrawal syndrome, however, remains unclear. The fact that beta adrenoreceptors in brain are not increased, but rather markedly reduced, during late withdrawal (32 hr) at a time when the primary abstinence syndrome is fully expressed suggests that beta adrenergic mechanisms are not crucial to the maintenance of opiate withdrawal.
